LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m 6 A-YTHDF2-dependent manner.
Yuan FangXi WuYunru GuRun ShiTao YuYutian PanJingxin ZhangXinming JingPei MaYongqian ShuPublished in: Clinical and translational medicine (2023)
A-YTHDF2-dependent manner, and targeting ALKBH5 may be a promising therapeutic method for GC patients.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- cell proliferation
- cancer therapy
- patient reported outcomes
- mass spectrometry
- high resolution
- binding protein
- gas chromatography
- tandem mass spectrometry
- solid phase extraction
- simultaneous determination